(Q34106943)

31 July 2017

1 reference

title

Systemic therapy of atopic dermatitis. (English)

1 reference

31 July 2017

1 reference

Sidbury R

1

1 reference

PubMed ID

11122228

31 July 2017

Hanifin JM

series ordinal

2

1 reference

31 July 2017

1 October 2000

1 reference

Clinical and Experimental Dermatology

31 July 2017

1 reference

31 July 2017

25

1 reference

31 July 2017

7

1 reference

31 July 2017

559-566

1 reference

Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation.

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Tacrolimus: the drug for the turn of the millennium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Pityriasis rubra pilaris. Prolonged treatment with methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

How genetic defects are identified

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Azathioprine in dermatology: a survey of current practice in the U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

High dose gammaglobulin treatment for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Adverse effects of intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

The role of antihistamines in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Epogam evening primrose oil treatment in atopic dermatitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Traditional Chinese medicine for the treatment of dermatologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

Topical Treatment with Liposomes Containing T4 Endonuclease V Protects Human Skin In Vivo from Ultraviolet-Induced Upregulation of Interleukin-10 and Tumor Necrosis Factor-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00697.X

10.1046/J.1365-2230.2000.00697.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11122228